FDA approves apalutamide for castration-resistant prostate cancer.
Stephanie Trexler, PharmD Candidate
Advertisement
Articles by Stephanie Trexler, PharmD Candidate
Advertisement
Latest Updated Articles
Apalutimide for Prostate Cancer: What to KnowPublished: April 4th 2018 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Vaccination of 3 Or More Doses Reduces Incidence of COVID-19 Symptoms for Young Adults
2
Orforglipron Demonstrates Superior Glycemic Control for Type 2 Diabetes
3
Coming Full Circle: How Mike Brundage Built a Thriving Pharmacy in Rural Pennsylvania
4
FDA Approves First 1-Minute Self Test for HIV
5
